Lindsay Meyer

Lindsay Meyer

President at Batch, Inc.

Health Technology
Finance
Consumer Services

Profile

Ms. Lindsay Meyer is Investment Analyst at Canaan Partners.
She joined Canaan Partners in 2011 as an Investment Analyst on the Healthcare team.
Prior to joining Canaan, she was a Senior Consultant at Deloitte Recap LLC.
At Recap, Lindsay analyzed trends in alliance formation and licensing, assisted with the firms expert witness testimony, and worked on consulting projects for biopharmaceutical clients.
Prior to Recap, she was an Analyst at CV Therapeutics (CVT), a cardiovascular drug company located in Palo Alto.
At CVT, she was responsible for the company’s investor relations activities and supported the senior management team in a variety of strategic initiatives including a $385M European licensing agreement, a $185M royalty financing, and the company’s $1.4B sale to Gilead Sciences in April 2009.
She also worked in corporate finance at Amgen, Inc. and in investment management at Goldman, Sachs & Co. Ms. Meyer has a BS in Science-Business from the University of Notre Dameand served as president of the student-management investment fund.

Lindsay Meyer active positions

CompaniesPositionStart
President -
All active positions of Lindsay Meyer

Former positions of Lindsay Meyer

CompaniesPositionEnd
Corporate Officer/Principal -
Corporate Officer/Principal -
AMGEN INC. Corporate Officer/Principal -
Private Equity Analyst -
See the detail of Lindsay Meyer's experience

Training of Lindsay Meyer

University of Notre Dame Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lindsay Meyer's experience

Connections

1

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
AMGEN INC.

Health Technology

Private companies4

Health Technology

Finance

Finance

Technology Services

See company connections